| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |